drugset / Trial / NCT04449926

BCG and Plasma Amyloid in Non-Demented Adults

NCT04449926 ↗

Phase 2 Completed 49 enrolled Mindful Diagnostics and Therapeutics, LLC
NaSingle-groupOpen-labelPrevention

Summary

BCG vaccination, the most widely used vaccination in the world, is used to reduce risk of tuberculosis infection; it is used for other mycobacterial infections as well, benefiting leprosy and Buruli ulcer. BCG has "heterologous" effects that aids in an array of non-mycobacterial and viral infections as well as bladder cancer. It is the heterologous effect, sometimes called the "off-target" effect that may offer benefit in Alzheimer's disease. Population studies and studies of adults receiving BCG show a lessened risk of Alzheimer's disease. The study will see if BCG vaccination will alter a plasma test for amyloid, a biomarker for cerebral amyloid.

Timeline

Start
2020-11-09
Primary completion
2021-12-04
Completion
2021-12-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus of Calmette and Guerin Vaccine 0.1 ml Other

Indications